Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.1050
0.00 (0.00%)
Apr 10, 2026, 3:56 PM EST
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 33.2 million as of April 10, 2026. Its market cap has increased by 134.49% in one year.
Market Cap
33.20M
Enterprise Value
133.00M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 33.20M, an increase of 44.71%. That is a compound annual growth rate of 1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 33.20M | 15.45% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 61.67M |
| Medicenna Therapeutics | 54.22M |
| MedMira | 45.61M |
| BriaCell Therapeutics | 42.49M |
| Defence Therapeutics | 40.82M |
| Devonian Health Group | 33.37M |
| Microbix Biosystems | 33.13M |
| Telescope Innovations | 31.92M |